亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

High-Mobility Group Box 1 Preconditioning Protects Against Liver Ischemia-Reperfusion Injury

詳細技術說明
None
*Abstract
High mobility group box 1 (HMGB1) is a nuclear factor released extracellularly as a late mediator of lethality in sepsis as well as following necrotic but not apoptotic death. Here we demonstrate that in contrast to the proinflammatory role of HMGB1, preconditioning with HMGB1 results in protection from inflammation and organ injury following hepatic ischemia and reperfusion (I/R). Pretreatment of mice with HMGB1 significantly decreased liver damage after I/R in association with markedly lower serum TNF and IL-6 compared to controls. The protection observed in mice pretreated with HMGB1 was associated with a higher expression of IL-1R-associated kinase-M (IRAK-M), a negative regulator of toll-like receptor (TLR)-4 signaling compared to controls. We thus explored the possibility that HMGB1 preconditioning was mediated through TLR4 activation. HMGB1 preconditioning failed to provide protection in TLR4 mutant (C3H/HeJ) mice, but successfully reduced damage in TLR4 wild-type (C3H/HeOuj) mice. Use of HMGB1 as a preconditioning agent may be a potential strategy in settings of ischemic injury to decrease organ damage.Use of HMGB1 as a preconditioning agent may be a potential strategy in settings of ischemic injury to decrease organ damage.Non Provisional and PCT Patent Applications Filed
*Principal Investigation

Name: Timothy Billiar, Chairman

Department: Med-Surgery


Name: Mitchell Fink, Professor

Department: Med-Critical Care Medicine


Name: Kevin Tracey, Head, Cnt. for Patient Oriented Rsch

Department:


Name: Allan Tsung, Graduate Medical Trainee

Department: Med-Surgery

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備